Upstream Bio, Inc. (UPB) financial statements and ratios from SEC XBRL: revenue $2.85M (TTM), net margin -5026.0%, revenue growth 20.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.85M |
| Net Margin | -5026.0% |
| Revenue Growth (YoY) | 20.4% |
| EPS Growth (YoY) | -52.3% |
| FCF Growth (YoY) | 123.6% |
| Price / Book | 1.40 |
| Price / Sales | 107.48 |
| FCF Yield | -49.2% |
| Altman Z-Score | 14.57 (safe) |
| Sector P/E (Healthcare) | 21.7 |
UPB overview · UPB earnings · UPB KPIs · UPB investor relations · UPB ownership · UPB peers · UPB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.